April 14, 2026 · Form 4 insider transaction
REED ELIZABETH E sold 37,500 shares of Travere Therapeutics, Inc. at $41.07 per share, a transaction worth $1.54M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person.